ArticleInternational journal of molecular sciences2025
A Dual-Purpose Approach for an Anti-Emetic NK1R Antagonist as a Chemosensitizer and Cardioprotectant in a Preclinical Model of Triple-Negative Breast Cancer.
Miguel Muñoz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.